Business · 30/12/2024
FDA Releases Draft Guidance on Clinical Investigation Protocol Deviations
The FDA has released a draft guidance to help sponsors, investigators, and IRBs identify and report protocol deviations in clinical trials of drugs, biological products, and devices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →